Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 21 results found. Search for [ Torrent Pharma from USFDA ]

Results 1 to 21 of 21
PB Jayakumar
November 6, 2019
Most violations relate to rectifiable documentation, data maintenance, batch-wise consistent production quality, data on supply chain, stability issues, microbial contamination and quality checks


PTI
New Delhi, October 13, 2019
Torrent Pharma recalls drugs from US, Puerto Rico: As per the report, Torrent Pharma Inc is recalling 17,088 bottles of Losartan Potassium /Hydrochlorothiazide tablets, USP 50mg/12.5mg from the same markets.


BusinessToday.In
October 10, 2019
Torrent Pharma informed the bourses that it has received a warning letter dated 08-Oct-19 from the USFDA for its Indrad facility in Gujarat


PB Jayakumar
New Delhi, September 24, 2019
Ranitidine, an old molecule with sales of $412.4 million is found to have cancer-causing impurities


E Kumar Sharma
September 5, 2019
Even as smaller Indian companies are looking to grow their business in the US market, the larger focus is on leading pharma companies because the top 20 of them contribute 75 per cent to total pharma exports from India


PTI
July 11, 2019



PTI
July 11, 2019



BusinessToday.In
June 6, 2019
Share Market Update: All the sectoral indices closed on the red, with major declines seen in PSU Bank, which was down by almost 5.20 % and PVT bank down at 2%, followed by other major indices like Pharma, Realty, Media and Metal, each declining over 1%. 


BusinessToday.In
New Delhi, May 20, 2019
BSE Sensex is up 1445.67 points or 3.81 per cent at 39,376.44 and NSE Nifty is trading up by 420.70 or 3.69 per cent at 11,827.85, in the last hour of trade.


PTI
April 21, 2019



E Kumar Sharma
New Delhi, December 28, 2017
 The just concluded year, hurt Indian pharma companies in more ways than one


Avneet Kaur
November 17, 2016
Out of BSE 500 companies, 291 companies-- excluding BFSI and Oil & Gas companies -- showed clear signs of improvement in bottom line in the second quarter of FY17. Net profit for this group showed a healthy growth of 9 per cent over the corresponding quarter last year. The y-o-y percentage growth in the same period last year was 2.61 per cent.


By E. Kumar Sharma
Delhi, April 25, 2016
In the third quarter, Dr. Reddy's revenues from India rose 34 per cent from the corresponding quarter of the previous year (partly due to acquisition of a few established brands of Belgian company UCB in India). However, in March, the growth was 7 per cent.


E Kumar Sharma
December 18, 2015
Till end of November, over 170 inspections were held in India as against over 70 inspection and certainly much less than 100 conducted five years ago by the US regulator in India.


BT Online
New Delhi, December 1, 2015
Shares of Jubilant Life rallied 10 per cent after the drug firm received final approval from the USFDA for its generic version of anti-depressant Paxil tablets.


Joe C Mathew
October 1, 2015
The US Patent and Trademark Office's trial and appeal board quashed Novartis's patent claims stating they were obvious (and hence not inventions that merit patent protection).


IANS
Chennai, September 17, 2015
In the calendar year 2015 there have been mergers and acquisitions (M&A) worth $110 billion which is on track to exceed last year's record M&A of $140 billion, Jefferies said.


Lalit K Jha
Washington, January 31, 2015
The merger deal, once consummated, would create India's largest and world's fifth-biggest drug maker.


E Kumar Sharma
December 24, 2014
Sun Pharmaceutical's move to acquire Ranbaxy is arguably the high point of 2014 for the pharmaceutical sector.


PTI
New Delhi, August 6, 2012
Both the companies said they would immediately commence distribution of the product in the US market.


PAGES 1 OF 2  12